Pandemic is causing huge damage to human life and immense pressure on medical health facilities we are witnessing the second wave, which is more virulent, destructive, and stressful. This is leading to many other life-threatening complications. One of them is mucormycosis (Black fungus).
Hyderabad based SP Accure Labs Pvt Ltd (a leading and reputed pharma manufacturing company) is launching an alternative drug Amphotericin-B-Emulation for the effective treatment of Mucormycosis, the fungal infection better known as black fungus, whose growing incidence is the latest health worry for the nation grappling with the second wave of covid-19. This new drug will be available in the market in a week at INR Rs. 5400 per injection.
P Girish Bhat, Managing Director, Medihauxe said “currently we have 10000 vials of the medicine in stock which is sufficient to treat around 1000 patients.”
Medihauxe pharma (a renowned pharma distribution company) from Hyderabad has been exclusively authorized to distribute this newly launched remedy in the market comprising of hospitals and patients in the state of Telangana. Medihauxe will strictly follow all the guidelines, discipline, and regulations laid down by the DMHS while performing their assigned service profile. Medihauxe has a highly satisfactory infrastructure and warehouse facilities, their state-of-the-art supply chain and cold chain make them an automatic choice for the proposed profile. Medihauxe is managed and directed by Mr. Girish Bhat and financed by Mr. Manohar Bhat, who are legends in the field of pharma distribution service. they have been serving the nation for the past 3 decades now. Expect the best from team Medihauxe.